靶向脑蛋白质组学揭示阿尔茨海默痴呆的多条通路
研究纳入834例社区老年人,死亡后行脑活检,用靶向蛋白质组学定量12个基因的皮质蛋白丰度,分析其与β-淀粉样蛋白负荷、神经病理指标及认知下降的关联。PLXNB1较高与β-淀粉样蛋白负荷和PHFtau缠结密度较高相关,且其与认知下降的关联由这些病理介导;IGFBP5、HSPB2、AK4较高和ITPK1较低与更快认知下降相关,且不被常见神经病理指标完全解释。
要点
- PLXNB1丰度较高与更多β-淀粉样蛋白负荷(p=1.0×10-7)和更高PHFtau缠结密度(p=2.3×10-7)相关。
- IGFBP5、HSPB2、AK4较高和ITPK1较低与更快认知下降相关,未被常见神经病理完全解释。
- 研究提示两条分子通路:一条影响β-淀粉样蛋白沉积,另一条影响认知韧性而无已知病理足迹。
核心结论
- 靶向蛋白质组学识别出与阿尔茨海默痴呆相关的皮质蛋白,并初步区分影响β-淀粉样蛋白沉积与影响认知韧性而无已知病理足迹的两条分子通路。
研究设计与样本
- 数据来自834名社区老年人,每年随访、死亡后行脑活检,采用统一结构化尸检评估β-淀粉样蛋白及其他常见年龄相关神经病理。
- 采用选择反应监测定量12个基因的皮质蛋白丰度,这些基因来自与阿尔茨海默痴呆相关的衰老人脑分子网络。
- 用回归和线性混合模型分析蛋白与β-淀粉样蛋白负荷、其他神经病理指标及死亡前多年认知下降的关联。
主要发现
- 死亡时平均年龄88.6岁,349名参与者(41.9%)在死亡时患有阿尔茨海默痴呆。
- PLXNB1丰度较高与更多β-淀粉样蛋白负荷相关(p=1.0×10-7),与更高PHFtau缠结密度相关(p=2.3×10-7)。
- PLXNB1与认知下降的关联由这些已知阿尔茨海默病病理介导。
- IGFBP5、HSPB2、AK4较高和ITPK1较低与更快认知下降相关,且这些关联未被常见神经病理指标完全解释。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Previous gene expression analysis identified a network of coexpressed genes that is associated with β-amyloid neuropathology and cognitive decline in older adults. The current work targeted influential genes in this network with quantitative proteomics to identify potential novel therapeutic targets. METHODS: Data came from 834 community-based older persons who were followed annually, died, and underwent brain autopsy. Uniform structured postmortem evaluations assessed the burden of β-amyloid and other common age-related neuropathologies. Selected reaction monitoring quantified cortical protein abundance of 12 genes prioritized from a molecular network of aging human brain that is implicated in Alzheimer's dementia. Regression and linear mixed models examined the protein associations with β-amyloid load and other neuropathological indices as well as cognitive decline over multiple years preceding death. RESULTS: Average age at death was 88.6 years. Overall, 349 participants (41.9%) had Alzheimer's dementia at death. A higher level of PLXNB1 abundance was associated with more β-amyloid load (p = 1.0 × 10-7 ) and higher PHFtau tangle density (p = 2.3 × 10-7 ), and the association of PLXNB1 with cognitive decline is mediated by these known Alzheimer's disease pathologies. On the other hand, higher IGFBP5, HSPB2, and AK4 and lower ITPK1 levels were associated with faster cognitive decline, and, unlike PLXNB1, these associations were not fully explained by common neuropathological indices, suggesting novel mechanisms leading to cognitive decline. INTERPRETATION: Using targeted proteomics, this work identified cortical proteins involved in Alzheimer's dementia and begins to dissect two different molecular pathways: one affecting β-amyloid deposition and another affecting resilience without a known pathological footprint. Ann Neurol 2018;83:78-88.
引用
- Yu L, Petyuk VA, Gaiteri C, et al. Targeted brain proteomics uncover multiple pathways to Alzheimer's dementia. Ann Neurol. 2018. PMID: 29908079. doi:10.1002/ana.25266
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。